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Abstract. 
 
RAP46 is a eukaryotic cochaperone that as-
sociates with several proteins, including the heat shock 
protein hsp70/hsc70 and the glucocorticoid receptor 
(GR). Here we show a downregulation of GR-medi-
ated transactivation by RAP46 via a mechanism inde-
pendent of a cytoplasmic action of this cochaperone. 
We demonstrate a speciﬁc cytoplasmic–nuclear recruit-
ment of RAP46 by the liganded GR that results in inhi-
bition of the transactivation function of the receptor. A 
 
repeated sequence motif [EEX
 
4
 
]
 
8
 
 at the NH
 
2
 
 terminus 
of RAP46 or BAG-1L, a larger isoform of RAP46, is re-
 
sponsible for this downregulation of GR activity. 
BAG-1, a shorter isoform with only a duplication of the 
[EEX
 
4
 
] sequence, does not inhibit GR activity. The 
[EEX
 
4
 
]
 
8
 
 motif, when linked to an otherwise unrelated 
protein, abrogated the inhibitory action of endogenous 
RAP46 on GR-mediated transactivation. The nuclear 
effects of RAP46 and BAG-1L are speciﬁc since GR-
mediated inhibition of AP-1 activity was not affected. 
These studies identify the [EEX
 
4
 
]
 
8
 
 sequence as a signa-
ture motif for inhibition of GR-mediated transactiva-
tion and demonstrate a speciﬁc nuclear action of a eu-
karyotic cochaperone in the regulation of GR activity.
Key words: glucocorticoid receptor • mineralocorti-
coid receptor • transactivation • BAG-1 isoforms • 
cochaperone
 
G
 
lucocorticoids
 
 function by binding to the gluco-
 
corticoid receptor (GR)
 
1
 
, which is localized in the
cytoplasm of target cells in a complex with the
heat shock proteins hsp90, p60/Hop, hsp70, hsp40, and
other chaperone molecules (for review see Pratt and Ditt-
mar, 1998). These proteins, particularly hsp90, hsp70, and
p60, keep the receptor in a form that is capable of binding
ligand (Dittmar and Pratt, 1997).
Molecular chaperones of the hsp70/hsc70 family play
important role in folding, translocation, and degradation
of proteins in eukaryotic cells due to their ability to bind
and stabilize nonnative protein conformation (Hartl, 1996;
Rassow et al., 1997). They recognize extended hydropho-
bic segments in substrates and bind them with their
COOH-terminal peptide domain while their NH
 
2
 
-terminal
ATPase domain is used for regulating the binding process
(Rassow et al., 1997). This occurs through cycles of ATP
binding and hydrolysis whereby denatured proteins are al-
ternatively bound and released to effect protein folding.
Substrates interact transiently with the ATP bound form
of hsp70, but this binding is stabilized when ATP is hydro-
lyzed (for review see Bukau and Horwich, 1998).
Members of the hsp40 and p60/Hop (hsp70/hsp90 orga-
nizing protein) families modulate the protein folding activ-
ity of hsp70 through interaction with the COOH-terminal
domain of this protein (Gebauer et al., 1997, 1998). In this
 
reaction, Hop plays a particularly interesting role and
establishes a physical link between hsp70 and hsp90
(Johnson et al., 1998). A protein termed Hip (hsc70 inter-
acting protein) has been identified as a chaperone cofactor
interacting with the ATPase domain of hsc70 after the ini-
tial activation of the ATPase activity by hsp40. Hip stabi-
lizes the ADP bound form of hsc70 and prolongs the inter-
 
action of this protein with various target substrates (Höhfeld
et al., 1995; Frydman and Höhfeld, 1997).
Recently, another member in the family of chaperones
and cochaperones has been identified and termed Hap46,
BAG-1, or RAP46. These different names originate from
the functions associated with this protein. For example,
Hap46 is derived from its function as an hsp70/hsc70 asso-
ciating protein (Gebauer et al., 1997, 1998; Höhfeld and
Jentsch, 1997; Takayama et al., 1997; Zeiner et al., 1997),
BAG-1 as a Bcl-2 associated athanogene 1 (Takayama et
al., 1995), and RAP46 as a steroid hormone receptor as-
sociating protein (Zeiner and Gehring, 1995). Hap46/
 
RAP46/BAG-1 interacts with the NH
 
2
 
-terminal ATP bind-
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Abbreviations used in this paper:
 
 GFP, green fluorescence protein; GR,
glucocorticoid receptor; HA, hemagglutinin influenza; HBD, hormone
binding domain; hsp, heat shock protein; MMTV, mouse mammary tumor
virus; MR, mineralocorticoid receptor.  
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ing domain of hsp70/hsc70 (Takayama et al., 1997; Stuart
et al., 1998) and competes with Hop, as well as Hip, for
binding to this molecular chaperone (Höhfeld and Jentsch,
1997; Gebauer et al., 1998). RAP46/BAG-1 interacts with
several other proteins through its COOH terminus, the
same region it uses to bind hsp70/hsc70 (Bardelli et al.,
1996; Wang et al., 1996; Takayama et al., 1997). Therefore,
it has been postulated that protein–protein interactions in-
volving this cochaperone must be mediated by hsp70/
hsc70 (Zeiner et al., 1997).
As a protein that associates with the antiapoptotic pro-
tein Bcl-2, overexpression of BAG-1 prolongs the survival
of fibroblasts challenged with apoptotic signals (Takayama
et al., 1995, 1997). It also interacts with hepatocyte and
PDGF receptors to enhance their antiapoptotic function
(Bardelli et al., 1996), while RAP46 interacts with steroid
receptors to inhibit apoptosis induced by some members
of this family of ligand binding transcription factors (Kull-
mann et al., 1998; Liu et al., 1998).
The action of RAP46 on steroid hormone action is com-
plicated by the fact that different isoforms of this protein
exist (Froesch et al., 1998). In addition to RAP46, also
known as BAG-1M, a larger isoform (BAG-1L) and a
smaller isoform (BAG-1) have been described. BAG-1L
arises through translation initiation at a noncannonical
CTG codon upstream and in-frame with the usual ATG
used for the production of RAP46, whereas BAG-1 is a
product of an in-frame translation at a downstream ATG
site (Froesch et al., 1998; Packham et al., 1997). BAG-1L
strongly enhances transactivation by the androgen recep-
tor, but BAG-1 and RAP46 do not drastically affect the ac-
tion of this receptor. On the other hand, BAG-1 inhibits
the transactivation activity of the retinoic acid receptor het-
erodimers (RAR/RXR), but not the homodimers (RXR/
RXR; Liu et al., 1998). As the different isoforms of RAP46
still contain their domain of interaction with hsp70/hsc70,
their effect on the action of the steroid receptor is thought
to be partially controlled by their cochaperone activity.
The effects of the various RAP46 isoforms on GR and ret-
inoic acid receptor activity so far have not been analyzed.
In this communication, we have analyzed the effect of
RAP46 and its isoforms on GR action. We have shown in
confocal immunofluorescence experiments colocalization
of RAP46 with the nontransformed GR in the cytoplasm.
However, this interaction does not affect the hormone
binding properties of the receptor. In the presence of
ligand, RAP46 is specifically recruited from the cytoplasm
into the nucleus by the activated GR. There, it uses its first
70 NH
 
2
 
-terminal amino acids containing the sequence
[EEX
 
4
 
]
 
8
 
 to inhibit DNA binding and, as a result transacti-
vation, but without compromising the ability of the recep-
tor to repress the activity of the transcription factor AP-1.
BAG-1L, the larger isoform of RAP46, which also con-
tains the sequence motif [EEX
 
4
 
]
 
8
 
, is constitutively nuclear.
It inhibited transactivation without a major effect on the
transrepression function of the receptor. Mutants of
RAP46 that are similar to BAG-1 with truncations of the
repeat motif do not affect GR activity. These results iden-
tify a signature motif on a eukaryotic cochaperone for in-
hibition of the transactivation function of the GR and
demonstrate that the primary site of action of this protein
is the nuclear compartment of cells.
 
Materials and Methods
 
Cell Culture
 
Simian kidney COS-7 cells and human mammary MCF-7 cells were cul-
tured in DME supplemented with 10% FCS, 100 U/ml penicillin, and 100
 
m
 
g/ml streptomycin at 37
 
8
 
C in an atmosphere of 5% CO
 
2
 
. For experi-
ments involving the use of the human mineralocorticoid receptor (MR),
the cells were kept in DME containing 3% charcoal treated FCS to re-
move residual steroids.
 
Plasmid Constructs
 
The expression vector containing the wild-type human GR and MR have
been described by Giguère et al. (1986) and Arriza et al. (1987). The re-
combinants GMM, GGM, and GG
 
D
 
 have been described by Arriza
(1991). The plasmid pcDNA3RAP46 was constructed by insertion of the
coding sequence of human RAP46 (Zeiner and Gehring, 1995) into the
plasmid pcDNA3. The expression plasmid pT2 contains sequences encod-
ing two copies of the hemagglutinin influenza (HA)-tag 5
 
9
 
-AA GCT TCC
ACC ATG ATC TTT TAC CCA TAC GAT GTT CCT GAC TAT GCG
GGC TAT CCC TAT GAC GTC CCG GAC TAT GCA GGA TCT
ACT CGA GAG GAT CCG GTA CCT ATC TAG A-3
 
9
 
 cloned between
the HindIII and XbaI sites of the plasmid pcDNA3 (Invitrogen Corp.).
The constructs pT2RAP46 and pT2RAP46
 
D
 
C47 were constructed by in-
serting blunt-ended BamHI/XbaI fragments from pcDNA3RAP46 and
pcDNA3RAP46
 
D
 
C47 (lacking the last 47 COOH-terminal amino acids)
into XhoI and XbaI sites of pT2 after a fill-in reaction with DNA poly-
merase I (Klenow fragment). The constructs pT2RAP46
 
D
 
40 and
pT2RAP46
 
D
 
70, containing deletion mutants of the first 40 and 70 NH
 
2
 
-
terminal amino acids of RAP46, were constructed by PCR amplification
with XhoI and BamHI ends and insertion into the corresponding sites of
pT2. The construct p46N69GFP, encoding the first 69 NH
 
2
 
-terminal
amino acids of RAP46 fused to the NH
 
2
 
 terminus of the green fluores-
cence protein (GFP) sequence, was obtained by subcloning a HaeIII/
PvuII fragment from pT2RAP46 into the blunt-ended HindIII site of
pcDNA3.1hGFP. The pcDNA3.1hGFP construct contains sequences en-
coding the humanized GFP (CLONTECH Laboratories, Inc.) between
the HindIII and XbaI sites of pcDNA3.1 (Invitrogen Corp.). The reporter
plasmid pGL3MMTV encodes the firefly luciferase gene under the con-
trol of the mouse mammary tumor virus (MMTV) long terminal repeat re-
gion (
 
2
 
241 to 
 
1
 
137), cloned as a BamHI/BglII fragment from the plasmid
pHCwt CAT (Kaspar et al., 1993). The reporter plasmid 
 
2
 
517/
 
1
 
63 Coll-
Luc already has been described by Heck et al. (1997) and Schneikert et al.
(1996). The control plasmid for transfection pTKRenilla Luc was obtained
from Promega and the expression vectors GR–GFP and GFP–MR have
been described by Carey et al. (1996) and Fejes-Tóth et al. (1998). The
GFP plasmids GR
 
D
 
491-515GFP and GR1-515GFP were constructed by
exchanging the GR sequence in the construct GR–GFP (Carey et al.,
1996) with the GR
 
D
 
491-515 and GR1-515 sequences (Hollenberg et al.,
1987).
 
Transient Transfections
 
100,000 MCF-7 cells were transiently transfected by the calcium phos-
phate coprecipitation procedure in 3.4-cm-diam plates with 2 
 
m
 
g reporter
plasmid, 0.1 
 
m
 
g pTKRenilla Luc, and 2 
 
m
 
g expression vector. After 5 h of
incubation with DNA and 2 min shock with 10% glycerol in PBS, the cells
were further incubated for 36 h. Thereafter, they were harvested and cel-
lular extracts were prepared for luciferase assay as described by Schneik-
ert et al. (1996). Renilla luciferase assay was performed with the dual
luciferase reporter assay system from Promega, according to the manufac-
turer’s instructions. COS-7 cells were transfected by electroporation as
previously described by Klocker et al. (1992) with 16.5 
 
m
 
g DNA contain-
ing 2 
 
m
 
g reporter plasmid, 0.5 
 
m
 
g pTKRenilla Luc, 7 
 
m
 
g wild-type or mu-
tant RAP46, and 7 
 
m
 
g receptor expression vector.
 
Whole Cell Hormone Binding Assay
 
COS-7 cells were transiently transfected with either empty expression vec-
tors or expression vectors encoding GR, RAP46, and RAP46
 
D
 
70. After
36 h incubation in DME containing 3% charcoal treated FCS, the cells
were trypsinized and resuspended in the same medium. 200,000 cells in
100 
 
m
 
l medium were incubated for 90 min at room temperature with dif-
ferent concentrations (0–100 nM) of [
 
3
 
H]dexamethasone (81.0 Ci/mmol; 
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Figure 1. Confocal immunofluorescence analysis of intracellular localization of GR, MR, and RAP46. COS-7 cells were transiently
transfected with expression vectors encoding either a GR–GFP (A and B) or GFP–MR (C and D) together with a plasmid expressing
HA-tagged RAP46 (A–D). 36 h after transfection the cells were treated for 1 h with vehicle (0.1% ethanol) alone (2) or vehicle con-
taining either 0.1 mM dexamethasone (1 Dex) or 0.1 mM aldosterone (1 Ald) before harvesting, processing, and visualization with a la-
ser confocal microscope. The green fluorescence arises from the GFP-tagged receptors, whereas the red fluorescence comes from stain-
ing of RAP46 with the anti-HA mAb 12CA5 (Boehringer Mannheim Corp.), followed by an anti-mouse antibody labeled with
rhodamine. The yellow to orange colors indicate areas of colocalization of the two proteins. 
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Nycomed Amersham Inc.) in the absence and presence of a 1,000-fold M
excess of unlabeled dexamethasone. After incubation, the cells were
washed three times with 1 ml PBS and recovered by centrifugation (3,800 
 
g
 
for 3 min). The cell pellet was then lysed in 5 ml scintillation fluid and the
radioactivity determined by liquid scintillation counting.
 
Immunofluorescence
 
Immunofluorescence experiments were performed as previously de-
scribed by Herscovics et al. (1994) and the photographs were taken with
an LSM 410 invert Zeiss confocal microscope.
 
Electrophoretic Mobility Shift Assays and Immunoblots
 
Electrophoretic mobility shift and immunoblots assays were performed as
described previously by Gast et al. (1995).
 
Results
 
Association and Recruitment of RAP46
 
RAP46 is a protein initially isolated by virtue of its associ-
ation with the GR in an interaction-screening assay
(Zeiner and Gehring, 1995). Since then, association of
RAP46 and the GR has been shown in vitro in a glu-
tathione S–transferase pull-down assay (Kullmann et al.,
1998). To determine whether these two proteins associate
in vivo, we performed immunofluorescence experiments
with RAP46 and the GR in the absence and presence of
hormone. To demonstrate the specificity of these interac-
tions, control experiments were carried out with the MR, a
structural and functional homologue of the GR (Arriza et
al., 1987).
When expressed in COS-7 cells, most of the RAP46 pro-
tein resided in the cytoplasm as determined by laser confo-
cal microscopy. Antibodies that recognize COOH-termi-
nal epitopes or the HA-tag on this protein clearly showed
cytoplasmic localization of RAP46 (Fig. 1, A 1 and C 1;
and results not shown). In certain regions of the cyto-
plasm, RAP46 colocalized with the unliganded GR or MR
(Fig. 1, see the yellow color in A 2 and C 2). In the absence
of hormone, the MR was identified in the cytoplasm, as
well as in the nucleus (Fig. 1, C 3), in agreement with the
results of Fejes-Tóth et al. (1998). In the presence of
ligand when the GR and MR are translocated from cyto-
plasm into the nucleus, RAP46 was transported with the
GR (Fig. 1, see yellow staining in the nucleus of B 2), but
not with the MR (Fig. 1, D 2), showing a specific in vivo
association of GR and RAP46. Note that cells containing
only RAP46, but not the GR, do not translocate into the
nucleus in the presence of dexamethasone (Fig. 1, com-
pare A 1 with B 1).
 
Effect of RAP46 on Ligand Binding and 
Transactivation by the GR
 
Through its association with the GR and MR in the cyto-
plasm, RAP46 may alter the ligand binding properties of
these receptors in line with its cochaperone activity (Stuart
et al., 1998). We therefore analyzed the hormone binding
properties of these receptors in the presence of RAP46 in
whole cells and in cytosol preparations. These studies re-
vealed only a slight change in the ligand binding activity of
the receptors in the presence of RAP46. For example,
Scatchard plot analysis showed an insignificant change in
 
the dissociation constant (K
 
d
 
) of the receptor for dexa-
methasone from 20 to 17 nM in the presence of RAP46
(Fig. 2, right). A slight (20%) reduction in the maximum
hormone binding capacity (B
 
max
 
) of the receptor was also
detected (Fig. 2, left). This downregulation of the B
 
max
 
 is
minimal compared with our previous report of a strong
RAP46-mediated inhibition of transactivation by the GR
(Kullmann et al., 1998). Thus, RAP46 must exert its neg-
ative regulatory function at other stages in the action of
the GR.
In the liganded state, when both the GR and MR are in
the nucleus, RAP46 downregulated the transactivation
function of only the GR, but not that of the MR (Fig. 3, A
and B; note that GGG and MMM refer to GR and MR).
This repression was independent of whether dexametha-
sone, cortisol, or aldosterone was the activating ligand
(Fig. 3 B). The lack of RAP46 effect on transactivation by
the MR is possibly due to the different cellular localiza-
tions of these two proteins in the presence of ligand (Fig.
1, D 2; note nuclear and cytoplasmic localization of MR
Figure 2. The effects of RAP46 and RAP46D70 on dexametha-
sone binding properties of the GR. 200,000 COS-7 cells were
transiently transfected with an empty expression vector or ex-
pression vectors encoding GR, RAP46, and RAP46D70. Thereaf-
ter, the cells were incubated with the indicated amounts of
[3H]dexamethasone in the presence or absence of 1,000-fold com-
petitor unlabeled dexamethasone and the bound radioactivity
was determined. This was done by subtracting the amount of ra-
dioactivity incorporated in the presence of competitor from the
radioactivity incorporated in the absence of the competitor. Left,
GR-bound [3H]dexamethasone is plotted as a function of hor-
mone concentration in cells transfected with only the GR expres-
sion vector (open circles), the GR and RAP46 (filled circles), the
GR and RAP46D70 (open squares), or with an empty expression
vector (open triangles). Presented are the mean values and error
bars of two different experiments. In each experiment, the indi-
vidual measurements were performed in triplicate. Right, The
Scatchard plots of the experiments indicating the Kd of GR for
dexamethasone in the presence or absence of RAP46 and
RAP46D70. 
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and RAP46). We therefore repeated the transfection ex-
periments with the MR and the RAP46 isoform BAG-1L,
which is constitutively localized in the nucleus (Froesch et
al., 1998; our unpublished results). In this study, transacti-
vation by the MR was not repressed by BAG-1L, although
the response of the GR was inhibited (results not shown;
see Fig. 7). This indicates a fundamental difference in the
action of RAP46 towards the MR and the GR.
GR–MR chimeric constructs were therefore used to
identify the regions of the GR necessary for repression by
RAP46 (Fig. 3 A). Two chimeric GR–MR constructs
(GMM and GGM), as well as a truncated GR construct
(GG
 
D
 
), were used in these analyses. Transactivation by the
chimeric MR receptor (GMM) containing the NH
 
2
 
-termi-
nal sequence of the GR (Arriza, 1991) in the presence of
either aldosterone, dexamethasone, or cortisol was not re-
pressed by RAP46 (Fig. 3 B). This may be due to the ab-
sence of the hinge region (amino acids 491–515) of the GR
that we previously identified as an interaction domain for
RAP46 and demonstrated its necessity for RAP46-medi-
 
ated inhibition of transactivation by the GR (Kullmann et
al., 1998). The presence of this domain in the chimeric con-
struct GGM still did not allow RAP46 to repress the trans-
activation function of this mutant receptor (Fig. 3 C), dem-
onstrating the need for the presence of the hormone
binding domain (HBD) of the GR. This finding was fur-
ther confirmed by the use of the truncated receptor
(GG
 
D
 
), which contains the interaction domain, but lacks
the HBD of the GR. In cotransfection experiments, this
mutant GR constitutively transactivated a glucocorticoid
responsive gene construct, but its activity was not re-
pressed by RAP46 (Fig. 3 C). Further control experiments
with chimeric receptors MGG and MMG were performed.
Transactivation by MGG containing both the hinge region
and HBD of the GR was repressed by RAP46, but not
transactivation by MMG containing only the HBD of the
GR, but not the hinge region of the GR (results not
shown). These results, together with our previous findings
on the hinge region (Kullmann et al., 1998), demonstrate
that this region, together with the HBD of the GR, are
Figure 3. Effect of RAP46 on ligand dependent transactivation by
GR and MR. A, Schematic diagram of the GR–MR chimeras show-
ing the GR in gray and the MR in stripes. The RAP46 binding site in
between amino acids 491 and 515 of the GR (Kullmann et al., 1998)
is presented as an unshaded region. The receptor chimeras described
have been reported previously by Arriza (1991). DBD, DNA bind-
ing domains. B and C, COS-7 cells were transiently cotransfected
with an MMTV firefly luciferase indicator gene and a renilla lu-
ciferase construct as an internal control, together with the indicated
MR and GR expression vectors in the presence of a RAP46 express-
ing plasmid (filled bars) or of the corresponding control vector
(open bars). Hormone treatment (0.1 mM dexamethasone, cortisol,
or aldosterone) was performed immediately after the transfection
and the cells were harvested 36 h later for luciferase activity mea-
surements. The results are expressed as the level of hormone-induced
expression of the MMTV construct after correcting for the transfec-
tion efficiency by renilla luciferase measurements. This was pre-
sented relative to the cortisol induced expression of the MMTV re-
porter plasmid by the GR, which was 213-fold, but was arbitrarily set
to unity. The bar chart represents the mean value (6 SD) of three
independent experiments. In B, the hormone used after transfection
was 0.1 mM cortisol and the level of induction of MMTV activity in
this case was 201-fold, but was also set arbitrarily to 1.0. In these ex-
periments, GGG and MMM stand for the GR and MR. 
The Journal of Cell Biology, Volume 146, 1999 934 
Schneikert et al. 
 
RAP46 in Downregulation of Glucocorticoid Receptor Activity
 
935
 
both required for RAP46-mediated inhibition of transacti-
vation by the GR.
 
The Role of the HBD of the Glucocorticoid Receptor in 
Repression by RAP46
 
To further determine the role of the HBD in the repres-
sion of the transactivating function of the GR by RAP46,
we asked whether this region is involved in the GR-medi-
ated recruitment of RAP46 into the nucleus. In laser con-
focal immunofluorescence experiments, we showed that
the GG
 
D
 
 mutant receptor lacking the HBD is perma-
nently localized in the nucleus in the absence and presence
of hormone, as already reported (Hollenberg et al., 1987).
However, in 
 
.
 
75% of the cells, RAP46 was colocalized
with the receptor in the nucleus (Fig. 4 A). Thus, the in-
ability of RAP46 to repress transactivation by GG
 
D
 
 is not
due to the preclusion of this protein from the nucleus.
Rather, it must be due to the absence of an important
function in the HBD required for the negative action of
RAP46.
To find out how RAP46 is recruited into the nucleus by
the GR, we used the mutant GR with a deletion of the
hinge region (amino acids 491–515) in the confocal immu-
nofluorescence experiments. In this study, both RAP46
and the mutant receptor were localized in the cytoplasm in
the absence of hormone. But, in the presence of dexa-
methasone, the ability of the GR to recruit RAP46 was se-
verely compromised (Fig. 4 B). Only 
 
z
 
50% of the cells
containing the mutant receptor and RAP46 showed colo-
calization of the two proteins in the nucleus (Fig. 4 B). In
the remaining cases, RAP46 was localized in the cyto-
plasm while the liganded receptor was translocated into
the nucleus (Fig. 4 B). This demonstrates that the hinge re-
gion of the GR is indeed involved in the transport of
RAP46 into the nucleus, although this process could be
aided by other regions of the receptor. These regions
are most likely contained in the HBD since its deletion,
as shown above, slightly decreased nuclear transport of
RAP46.
 
Nuclear Action of RAP46
 
As RAP46 does not drastically alter the hormone binding
properties of the GR in the cytoplasm, and it is translo-
cated into the nucleus by the GR, its major site of action
must be in the nucleus. Previously, we have shown that it
inhibits the DNA binding activity of the receptor (Kull-
mann et al., 1998), but the mechanism involved is not known.
We therefore deleted the NH
 
2
 
-terminal sequences of this
protein encompassing the sequence motif [EEX
 
4
 
]
 
8
 
 (see
underlined sequences in Fig. 5 A) to determine the effect
of the truncated proteins on DNA binding by the GR and
GR-mediated transactivation at the MMTV promoter.
 
While RAP46 inhibited DNA binding by the GR, mu-
tants with truncation of the first 40 or 70 NH
 
2
 
-terminal
amino acids, eliminating five or all eight of the repeat-
motif, partially or completely abolished this negative ef-
fect of RAP46 on DNA binding, as well as transactivation
by the GR (Fig. 5 B). Control immunoblot experiments
with extracts of the transfected cells showed that the GR
and RAP46 constructs were adequately expressed in this
experiment (Fig. 5 B). Note that the apparent complete in-
hibition of DNA binding by the GR in Fig. 5 B is due to
the very short autoradiographic exposure time of the gel.
Longer exposures showed that DNA binding was drasti-
cally repressed, but not completely abolished (results not
shown).
The two RAP46 NH
 
2
 
-terminal mutants behaved as the
wild-type RAP46 in several experiments. This was dem-
onstrated by RAP46
 
D
 
70, which slightly decreased the
maximum hormone binding capacity of the GR without
significantly affecting the K
 
d
 
 for dexamethasone, as we
have reported already (Fig. 2, compare K
 
d
 
 5 
 
20 nM with
19 nM). In the presence of ligand, this mutant, as in the
case of the wild-type RAP46, was also recruited into the
nucleus by the GR (Fig. 5 C, compare A 1 with B 2).
However, unlike the wild-type RAP46, it did not down-
regulate DNA binding by the GR, nor did it repress GR-
mediated transactivation at the MMTV promoter (Fig. 5
B). Thus, COOH-terminal sequences of RAP46 are re-
quired by the GR for the recruitment of this protein into
the nucleus.
To determine the sequences at the COOH terminus
necessary for the recruitment, we used a mutant RAP46
lacking the last 47 amino acids known to bind hsp70/hsc70
in immunofluorescence experiments (Froesch et al., 1998).
This mutant, unlike the NH
 
2
 
-terminal deletion construct,
was not transported into the nucleus (Fig. 5 D), indicating
that the extreme COOH-terminal sequence of RAP46 is
required to get this protein into the nucleus. Interestingly,
deletion of this COOH-terminal sequence also abolished
the repressive action of RAP46 on DNA binding by the
GR (results not shown). This demonstrates the necessity
for nuclear transport of RAP46 for its negative regulatory
activity. These results, together with our findings from
the experiments with the NH
 
2
 
-terminal deletion mutant
RAP46
 
D
 
70 (Fig. 5 C), demonstrate that although nuclear
transport of RAP46 is necessary, it is not sufficient for in-
hibition of DNA binding by the GR. This function re-
quires the NH
 
2
 
 terminus of RAP46.
To determine the contribution of the NH
 
2
 
 terminus of
RAP46 to downregulation of GR activity, we fused the
first 69 amino acids to GFP and asked whether such a con-
struct was sufficient in repressing GR activity. In immu-
nofluorescence experiments, this fusion protein was found
both in the cytoplasm and the nucleus (results not shown).
 
Figure 4.
 
Confocal immunofluorescence analysis of intracellular localization of mutant GR and RAP46. COS-7 cells were transiently
transfected with expression vectors encoding either a GR1-515-GFP (A) or GR
 
D
 
491-515-GFP (B), together with a plasmid expressing
HA-tagged RAP46. 36 h after transfection, the cells were treated for 1 h with vehicle (0.1% ethanol) alone (
 
2
 
) or vehicle containing
0.1 
 
m
 
M dexamethasone (
 
1
 
 Dex) before harvesting, processing, and visualization with a laser confocal microscope. The green fluores-
cence arises from the GFP-tagged receptors, whereas the red fluorescence comes from staining of RAP46 with the anti-HA mAb
12CA5 (Boehringer Mannheim Corp.), followed by an anti-mouse antibody labeled with rhodamine. The yellow to orange colors indi-
cate areas of colocalization of the two proteins. 
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In transactivation studies carried out in GR- and RAP46-
positive human mammary tumor MCF-7 cells (Cato et al.,
1986; Yang et al., 1998), overexpression of RAP46 inhib-
ited transactivation by the GR, as we had previously re-
ported (Kullmann et al., 1998; Fig. 5 B). However, overex-
pression of GFP alone had no effect on GR response,
whereas the N69GFP construct increased transactivation
by the endogenous GR (Fig. 6 A). This shows a dominant–
negative effect of the N69GFP protein on the repressive
action of endogenous RAP46 in GR-mediated transactiva-
tion. This dominant–negative effect was further demon-
strated in DNA binding studies involving the GR. In this
assay, the N69GFP fusion protein, but not GFP alone,
abolished the repressive action of RAP46 on DNA bind-
ing by the GR (Fig. 6 B, compare lanes 2–4 with lanes 5–7).
These studies confirm that RAP46 uses its NH
 
2
 
-terminal
sequence for the repression of GR activity, possibly
through interaction with other factors since its negative ef-
fect could be competed by an excess of the N69 sequence
fused to GFP.
 
RAP46 Isoforms (Transactivation
Versus Transrepression)
 
To further determine the significance of the [EEX
 
4
 
]
 
8
 
 motif
in the negative action of RAP46, we examined the effect
of the RAP46 isoform BAG-1L (which also carries this se-
quence motif) on DNA binding by the GR and transacti-
vation by this receptor at the MMTV promoter. In these
experiments, both RAP46 and BAG-1L negatively regu-
lated the DNA binding and transactivation functions of
the GR to the same extent (Fig. 7). BAG-1, the isoform of
RAP46 that lacks a considerable portion of the repeat mo-
tif, had no effect, as we have already shown for its closely
related homologue RAP46
 
D
 
40 (unpublished results; see
also Fig. 5 B).
Since the nuclear action of the GR involves both posi-
tive and negative regulation of gene expression (Beato et
al., 1995; Cato and Wade, 1996; McEwan et al., 1997), we
examined the effect of RAP46 and BAG-1L on the nega-
tive regulatory activity of the GR. This was achieved by
measuring the ability of the GR to repress the expression
of a human collagenase I gene construct induced by the
phorbol ester 12-O-tetradecanoyl phorbol 13-acetate (TPA).
This study showed that transrepression was unaffected by
RAP46, whereas BAG-1L only slightly (30%) abrogated
this function of the GR (Fig. 7). These effects remained
unchanged, even when different amounts of the two con-
structs were transfected (results not shown). These find-
ings show that the transactivating and transrepressing
functions of the GR are regulated differently by RAP46.
They further demonstrate that the major nuclear action of
Figure 5. Regions of RAP46 required for nuclear transport and inhibition of GR activity. A, Schematic representation of different iso-
forms and deletion mutants of RAP46. Indicated are the isoforms BAG-1L, RAP46, and BAG-1, as well as the deletion mutants
RAP46D40 and RAP46D70. The black vertical bars indicate the positions of the motif [EEX4]. The gray and hatched areas represent
the location of a proline rich region (Pro) and of a putative nuclear localization signal (NLS). The sequence of the first 71 NH2-terminal
amino acids of RAP46 is also shown with the arrows pointing to the first amino acid in RAP46, RAP46D40, BAG-1, and RAP46D70.
Each [EEX4] motif is underlined. B, Lack of effect of a NH2-terminal deletion mutant of RAP46 on DNA binding by the GR and trans-
activation by the receptor at the MMTV promoter. COS-7 cells were transiently transfected with a control vector (lanes 1 and 2) or an
expression vector for GR (lanes 3–10). In addition, they were cotransfected with either a control vector (lanes 1–4) or a plasmid encod-
ing the wild-type HA-tagged RAP46 (HA-RAP46 wt, lanes 5 and 6) or deletion mutants lacking either the first 40 amino acids (HA-
RAP46D40, lanes 7 and 8) or the first 70 amino acids (HA-RAP46D70, lanes 9 and 10). After treatment with vehicle (0.1% ethanol)
alone (2 Dex) or with 0.1 mM dexamethasone (1 Dex) for 36 h, whole cell extracts were prepared for EMSA and for GR or RAP46 im-
munoblot analysis. The cells were also transfected with the MMTV firefly luciferase indicator construct and an internal control encod-
ing the renilla luciferase. Hormone treatment was performed with 0.1 mM dexamethasone. The results are expressed as dexamethasone-
induced activity of the MMTV indicator gene presented relative to the induced level in the absence of RAP46 that was set at unity. The
bar chart represents the mean value (6 SD) of three independent experiments. C and D, Confocal immunofluorescence analysis of in-
tracellular localization of GR and HA-RAP46D70 or HA-RAP46DC47 constructs. COS-7 cells were transiently transfected with expres-
sion vectors encoding a GR–GFP and HA-tagged RAP46D70 (C) or GR–GFP and HA-tagged RAP46DC47 (D). 36 h after transfec-
tion, the cells were treated for 1 h with vehicle (0.1% ethanol) alone (2) or vehicle containing 0.1 mM dexamethasone (1 Dex) before
harvesting, processing, and visualization with a laser confocal microscope. The green fluorescence arises from the GFP-tagged receptor,
whereas the red fluorescence comes from staining of RAP46D70 and RAP46DC47 with the anti-HA mAb 12CA5, followed by an anti-
mouse antibody labeled with rhodamine. The yellow to orange colors indicate areas of colocalization of the two proteins.Schneikert et al. RAP46 in Downregulation of Glucocorticoid Receptor Activity 937
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RAP46, and its isoform BAG-1L, on GR activity is the re-
pression of the transactivation function of this receptor.
Discussion
hsp70 and hsp90 provide the GR with the proper confor-
mation for ligand binding and, therefore, play an impor-
tant role in the ligand-mediated activation of this receptor
(Hutchinson et al., 1994; Dittmar and Pratt, 1997; Dittmar
et al., 1998). In this study we have shown that RAP46, a
protein that binds hsp70 to inhibit its ability to refold de-
natured proteins (Gebauer et al., 1997, 1998), downregu-
lates transactivation by the GR. This negative regulation
does not involve inhibition of the ability of the receptor to
bind hormone. In hormone binding studies, RAP46 did
not alter the Kd of the receptor for its ligand. We therefore
concluded that the negative regulation of GR activity by
RAP46 must occur through other mechanisms.
We demonstrated by immunofluorescence experiments
that in the presence of ligand, RAP46 is recruited from the
cytoplasm into the nucleus by the GR, but not by the MR.
As RAP46 binds hsp70/hsc70, the nuclear transfer could
occur via this heat shock protein, especially since it is re-
ported to be transported into the nucleus by both the GR
and MR (Diehl and Schmidt, 1993; Srinivasan et al., 1994;
Bruner et al., 1997). However, if RAP46 were to be trans-
ported via its interaction with hsp70/hsc70, it would be ex-
pected to be recruited into the nucleus by both receptors.
Since only the GR, but not the MR, recruited RAP46 into
the nucleus, it is very likely that the nuclear transport is
mediated by a specific association of RAP46 with the GR.
Previously, we have shown in glutathione S–transferase
pull-down experiments that the hinge region of the GR
(amino acids 491–515) is necessary for the association of
RAP46 with the GR. In those experiments, we showed
that deletion of this region abolished RAP46-mediated
downregulation of transactivation by the GR (Kullmann
et al., 1998). In the present study, we have shown that de-
letion of the hinge region partially decreased the ability of
RAP46 to be transported into the nucleus by the GR. This
means that the hinge region has at least two functions.
First, it contributes to nuclear recruitment of RAP46 and
second, it also plays a role in inhibition of GR-mediated
transactivation. As the hinge region of the GR differs con-
siderably in sequence from that of the MR, it could explain
why RAP46 is not translocated into the nucleus by the MR
and why transactivation by this receptor is not repressed
by RAP46.
In our study to find out which region of RAP46 is re-
quired for recruitment into the nucleus, we used a mutant
that lacks the last 47 COOH-terminal amino acids known
Figure 6. Dominant–negative
effect of the first 69 NH2-ter-
minal amino acids of RAP46
on transactivation and DNA
binding by the GR. A, GR-
mediated enhancement of
transactivation by the first 69
NH2-terminal amino acids of
RAP46 fused to GFP. MCF-7
cells were transiently trans-
fected with the MMTV fire-
fly luciferase indicator gene
and the internal control
pTKRenilla-Luc construct,
as well as plasmids encoding
either RAP46, GFP, or
N69GFP. Dexamethasone
treatment (0.1 mM) was per-
formed immediately after
the transfection. Shown are
results of the dexametha-
sone-induced MMTV activ-
ity expressed relative to
unity, which is the value
given to the hormone in-
duced activity of the indica-
tor plasmid in the presence of the empty expression vector. The
bar charts represent the mean value (6 SEM) of two indepen-
dent experiments. B, The N69GFP fusion overcomes the inhibi-
tory effect of RAP46 on DNA binding by the GR. Shown are the
EMSA and immunoblots with extracts of COS-7 cells transiently
transfected with either a control vector (lane 1) or a plasmid en-
coding GR (lanes 2–7). In addition, the cells were transfected
with constructs encoding HA-RAP46 (lanes 5–7), the empty ex-
pression vector pcDNA3 (lanes 1, 2, and 5), GFP (lanes 3 and 6),
or the N69GFP fusion (lanes 4 and 7). After transfection, the
cells were treated with 0.1 mM dexamethasone for 36 h and cellu-
lar extracts were prepared for the EMSA and immunoblot assay.
Figure 7. Effect of RAP46
and BAG-1L on DNA-bind-
ing, transactivation, and tran-
srepression by the GR. COS-7
cells were transiently trans-
fected with either a control
vector, a plasmid encoding
the GR, RAP46, or BAG-
1L. After transfection, the
cells were treated with 0.1
mM dexamethasone for 36 h
and whole cell extracts were
prepared for EMSA. In addi-
tion, the effect of RAP46 and
BAG-1L on transactivation
at the MMTV promoter and
GR-mediated repression at
the human collagenase I pro-
moter were analyzed. MCF-7
cells were transiently trans-
fected with a control vec-
tor or a plasmid encoding
RAP46 or BAG-1L, in addi-
tion to the MMTV firefly lu-
ciferase indicator or collage-
nase luciferase constructs
and a plasmid encoding the
renilla luciferase as an inter-
nal control. The activity of the collagenase promoter was induced
with 80 ng/ml TPA and the cells were treated immediately after
transfection with vehicle alone (0.1% ethanol; 2) or 0.1 mM dexa-
methasone (1) for 36 h. The bar chart shows the normalized lu-
ciferase activity (firefly/renilla) of the MMTV and collagenase
gene constructs. The results represent the mean value (6 SD) of
three independent experiments.Schneikert et al. RAP46 in Downregulation of Glucocorticoid Receptor Activity 939
to bind hsp70/hsc70 (Froesch et al., 1998). This protein was
not translocated into the nucleus by the GR, implicating
the hsp70/hsc70 binding site in the nuclear transport of
RAP46. Thus, binding of hsp70/hsc70 to RAP46 may be
involved in the nuclear transport and the heat shock pro-
tein must interact differently with the GR and MR to ac-
count for the differences observed in the recruitment of
RAP46 into the nucleus by these two receptors. Alterna-
tively, hsp70/hsc70 may not be necessary at all, but the
same sequence used for binding the heat shock protein
may be involved in a direct interaction with the GR. This
would mean that RAP46 must compete with hsp70/hsc70
for binding to the GR. Our experiments so far do not dis-
tinguish between these possibilities.
We have shown that, although nuclear recruitment of
RAP46 is necessary, it is not sufficient for negative regula-
tion of GR activity. A RAP46 protein lacking the first 70
amino acid residues was transported into the nucleus by
the GR, but nevertheless failed to inhibit transactivation
by the receptor. This indicates that the inhibitory function
of RAP46 requires its NH2-terminal sequences. This re-
gion of RAP46 is possibly involved in interaction with
other proteins, since a fusion protein containing this seg-
ment exerted a strong dominant–negative function and re-
lieved the downregulatory action of RAP46 on transacti-
vation by the GR. The first NH2-terminal 70 amino acids
of RAP46 contain a sequence motif [EEX4]8 that may con-
tribute to the downregulation of transactivation by the GR
since BAG-1L which contains this motif, but not BAG-1,
also repressed GR-mediated transactivation. BAG-1, on
the other hand contains two copies, rather than the eight
copies of the [EEX4] motif. Thus, whatever the function of
this sequence, several copies, rather than a duplication, are
necessary for the manifestation of its repressive function.
The [EEX4]8 sequence is highly enriched in threonine and
serine residues (27% of the total sequence). Our prelimi-
nary in vivo labeling studies showed that RAP46 is a phos-
phoprotein, with almost all its phosphorylated residues lo-
calized at the [EEX4]8 sequence in the first NH2-terminal
70 amino acid residues (Schneikert, J., and A.C.B. Cato,
unpublished). This finding is rather striking and highly
suggestive of a role of phosphorylation in the action of the
NH2 terminus of RAP46.
Inhibition of GR-mediated transactivation by the core-
pressor calreticulin has been shown to be dependent on in-
hibition of DNA binding brought about by the interaction
of this protein with sequences in the DNA binding domain
of the receptor (Burns et al., 1994). Distinct sequences in
the DNA binding domain of the GR are not recognized by
RAP46 for the inhibition of transactivation by the GR.
The site of interaction of RAP46 on the GR is the hinge
region (Kullmann et al., 1998; present results). However,
the HBD of the GR also contributes to the negative action
of RAP46. From our studies, we conclude that the nega-
tive action of RAP46 is effected through a prior nuclear
transport of this protein via a process that requires the
COOH-terminal region (the hinge region and, to some ex-
tent, the HBD) of the GR, as well as the last 47 COOH-
terminal amino acids of RAP46. In the nucleus, RAP46 in-
hibits DNA binding by the receptor through a mechanism
that is not quite clear at the moment. The fact that the
HBD of the GR binds hsp70/hsc70, which is also recog-
nized by RAP46, and all three proteins are found in the
nucleus, argues in favor of at least a tertiary protein com-
plex in the negative regulatory action of RAP46. Other
proteins may be part of this complex as well, especially
protein binding to the NH2-terminal region of RAP46.
We have demonstrated that the inhibitory action of
RAP46 is specific for those actions of the GR requiring
DNA binding. Thus, transactivation, which is dependent
on DNA binding by the GR is repressed, but not GR-
mediated repression of the activity of the transcription factor
AP-1, which does not require DNA binding by the recep-
tor (Heck et al., 1994). We cannot, however, rule out the
possibility that the use of TPA for the activation of AP-1
in our experiments disrupts the RAP46 complex necessary
for inhibiting GR action.
The biological significance of the negative regulatory ac-
tion of RAP46 are manifold. We previously have shown
that RAP46-mediated inhibition of transactivation by the
GR correlates with inhibition of glucocorticoid induced
apoptosis (Kullmann et al., 1998). We also observed that T
cells that are resistant to glucocorticoid-induced apoptosis
express relatively high levels of RAP46 (Kullmann et al.,
1998). Conversely, conditions that downregulate the en-
dogenous levels of RAP46, such as exposure of thymoma
cells to the immunosuppressant rapamycin, enhanced the
transactivation potential of the GR and reduced GR-medi-
ated apoptosis (Kullmann et al., 1998). In the present
study we have shown, by the use of a dominant–negative
mutant construct, that the transactivation function of the
GR in the human mammary carcinoma MCF-7 cells is
negatively regulated by endogenous RAP46. As neoplastic
cells generally express relatively high levels of RAP46 and
BAG-1L (Takayama et al., 1998; Yang et al., 1998), our re-
sults on the inhibition of GR-mediated transactivation by
these proteins may provide mechanistic explanations for
the reported cases of glucocorticoid resistance in neoplas-
tic transformation. This point would have to be taken into
consideration in studies on glucocorticoid resistance in dis-
orders such as acute lymphocytic and nonlymphocytic leu-
kemia (Crabtree et al., 1981; Wells et al., 1981).
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